182781842	182781842	CD	B-NP	O
|	|	NN	I-NP	O
BADCMC	BADCMC	NN	I-NP	O
|	|	NN	I-NP	O
49695934	49695934	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0036245	0036245	CD	B-NP	O
|	|	CC	I-NP	O
2/23/2006	2/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
HEAD	HEAD	NNP	I-NP	O
TRAUMA	TRAUMA	NNP	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
FALL	FALL	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/26/2006	10/26/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/1/2006	8/1/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WISDOM	WISDOM	NNP	B-NP	O
,	,	,	O	O
BRUNO	BRUNO	NNP	B-NP	O
ELTON	ELTON	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Intracranial	Intracranial	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
AND	AND	CC	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
DVTs	DVT	NNS	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
lumpectomy	lumpectomy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
AICD	AICD	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
admitted	admit	VBD	B-VP	O
10/30/06	10/30/06	CD	B-NP	O
after	after	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
VFib	VFib	NN	I-NP	O
arrest	arrest	NN	I-NP	O
with	with	IN	B-PP	O
AICD	AICD	NN	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-NP	O
fall	fall	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
limits	limit	NNS	I-NP	O
history	history	NN	I-NP	O
but	but	CC	B-PP	O
per	per	IN	B-PP	O
prior	prior	JJ	B-NP	O
notes	note	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
fell	fall	VBD	B-VP	O
on	on	IN	B-PP	O
11/19/06	11/19/06	CD	B-NP	O
with	with	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
or	or	CC	I-NP	O
three	three	CD	I-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
feeling	feeling	NN	B-NP	O
dizzy	dizzy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
8/10	8/10	CD	B-NP	O
headaches	headache	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
RN	RN	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
assisted	assist	VBN	I-NP	O
living	living	NN	I-NP	O
facility	facility	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
be	be	VB	B-VP	O
evaluated	evaluate	VBN	I-VP	O
immediately	immediately	RB	B-ADVP	O
postfall	postfall	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complains	complain	NNS	I-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
postfall	postfall	NN	I-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
until	until	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Headache	Headache	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
constant	constant	JJ	B-ADJP	O
since	since	IN	B-PP	O
fall	fall	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
complains	complain	NNS	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
CT	CT	NN	I-NP	O
noted	note	VBD	B-VP	O
intracranial	intracranial	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
,	,	,	O	O
subdural	subdural	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
subarachnoid	subarachnoid	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
3.3	3.3	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Neurosurgical	Neurosurgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
from	from	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
to	to	TO	B-PP	O
10/17/06	10/17/06	CD	B-NP	O
without	without	IN	B-PP	O
operative	operative	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
received	receive	VBD	B-VP	I-protein
factor	factor	NN	B-NP	I-protein
VII	VII	CD	I-NP	I-protein
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
subcutaneous	subcutaneous	JJ	B-NP	O
vitamin	vitamin	NN	I-NP	O
K	K	NN	I-NP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
seizure	seizure	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
Dilantin	Dilantin	NNP	B-NP	O
and	and	CC	I-NP	O
Keppra	Keppra	NNP	I-NP	O
,	,	,	O	O
followed	follow	VBD	B-VP	O
closely	closely	RB	B-ADVP	O
by	by	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
EEG	EEG	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

ICU	ICU	NN	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
slowly	slowly	RB	B-NP	O
rising	rise	VBG	I-NP	O
LFTs	LFT	NNS	I-NP	B-protein
ascribed	ascribe	VBN	B-VP	O
to	to	TO	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
persistent	persistent	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Again	Again	NNP	B-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
DVTs	DVT	NNS	B-NP	O
,	,	,	O	O
lumpectomy	lumpectomy	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
mastectomy	mastectomy	NN	B-NP	O
for	for	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
;	;	:	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
NSVTs	NSVT	NNS	B-NP	B-protein
with	with	IN	B-PP	O
AICD	AICD	NN	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
MIs	MI	NNS	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
assisted	assist	VBN	I-NP	O
living	living	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
ethanol	ethanol	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-VP	O
shrimp	shrimp	VB	I-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.15	0.15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
175	175	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	O	O
every	every	DT	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
nightly	nightly	RB	I-NP	O
,	,	,	O	O
Dilantin	Dilantin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
p.o.	p.o.	FW	I-NP	O
everyday	everyday	NN	I-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
q.	q.	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
simethicone	simethicone	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
levocarnitine	levocarnitine	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
250/50	250/50	CD	I-NP	O
INH	INH	NNP	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	NNP	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
29	29	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
oxycodone	oxycodone	NN	I-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
,	,	,	O	O
Zofran	Zofran	NNP	B-NP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
TO	TO	NN	I-NP	O
FLOOR	FLOOR	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
68	68	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/70	140/70	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
somnolent	somnolent	JJ	B-ADJP	O
,	,	,	O	O
seated	seat	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
,	,	,	O	O
responding	respond	VBG	B-VP	O
to	to	TO	B-PP	O
voice	voice	NN	B-NP	O
,	,	,	O	O
answers	answer	VBZ	B-VP	O
single	single	JJ	B-NP	O
questions	question	NNS	I-NP	O
appropriately	appropriately	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
intermittently	intermittently	RB	I-VP	O
requiring	require	VBG	I-VP	O
painful	painful	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
for	for	IN	B-PP	O
arousal	arousal	NN	B-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
sclerae	sclerae	NNS	B-NP	O
were	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
jaw	jaw	VB	I-VP	O
movement	movement	NN	B-NP	O
and	and	CC	I-NP	O
tooth	tooth	JJ	I-NP	O
grinding	grinding	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
and	and	CC	I-NP	O
apex	apex	NN	I-NP	O
,	,	,	O	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
both	both	CC	O	O
lung	lung	NN	B-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
and	and	CC	O	O
tympanic	tympanic	NN	B-NP	O
.	.	.	O	O

Nonpitting	Nonpitting	JJ	B-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Dorsalis	Dorsalis	NNP	B-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
occasionally	occasionally	RB	B-ADVP	O
answers	answer	VBZ	B-VP	O
questions	question	NNS	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
when	when	WRB	B-ADVP	O
awake	awake	NN	B-NP	O
,	,	,	O	O
followed	follow	VBD	B-VP	O
command	command	NN	B-NP	O
intermittently	intermittently	RB	B-ADVP	O
,	,	,	O	O
tracking	track	VBG	B-VP	O
when	when	WRB	B-ADVP	O
awake	awake	NN	B-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
cooperation	cooperation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
her	her	PRP$	B-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
gross	gross	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
147	147	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
64	64	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.4	9.4	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.5	2.5	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
90	90	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	B-cell_line
111	111	CD	I-NP	I-cell_line
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
was	be	VBD	B-VP	O
4	4	CD	B-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
was	be	VBD	B-VP	O
2.3	2.3	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
7.1	7.1	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
175	175	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.9	3.9	CD	I-NP	I-protein
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
37.8	37.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
227	227	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
leukocyte	leukocyte	NN	I-NP	O
esterase	esterase	NN	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1764	1764	CD	B-NP	O
,	,	,	O	O
ammonia	ammonia	NN	B-NP	O
48	48	CD	I-NP	O
.	.	.	O	O

Dilantin	Dilantin	NN	B-NP	O
level	level	NN	I-NP	O
10.8	10.8	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
73	73	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
first-degree	first-degree	JJ	B-NP	O
AVB	AVB	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
IVCD	IVCD	NN	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
on	on	IN	B-PP	O
1/18/06	1/18/06	CD	B-NP	O
,	,	,	O	O
dilated	dilate	VBN	B-VP	O
left	leave	VBD	B-VP	O
ventricle	ventricle	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
July	July	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
septum	septum	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
apex	apex	NN	B-NP	O
.	.	.	O	O

Mildly	Mildly	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurg	regurg	NN	I-NP	O
,	,	,	O	O
dilated	dilated	JJ	B-NP	O
and	and	CC	I-NP	O
nonpulsatile	nonpulsatile	JJ	I-NP	O
IVC	IVC	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
PA	PA	NN	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
with	with	IN	B-PP	O
prominent	prominent	JJ	B-NP	O
septa	septa	NN	I-NP	O
interstitium	interstitium	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

AP	AP	NN	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
1/18/06	1/18/06	CD	B-NP	O
appear	appear	VBP	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
mild-to-moderate	mild-to-moderate	JJ	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
airspace	airspace	NN	I-NP	O
disease	disease	NN	I-NP	O
worse	worse	JJR	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Appearances	Appearance	NNS	B-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
asymmetric	asymmetric	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
device	device	NN	I-NP	O
overlies	overlie	VBZ	B-VP	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
wall	wall	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
terminating	terminating	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
was	be	VBD	B-VP	O
visualized	visualize	VBN	I-VP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
sono	sono	NN	I-NP	O
10/30/06	10/30/06	CD	I-NP	O
,	,	,	O	O
hepatic	hepatic	JJ	B-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
limited	limited	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
contraction	contraction	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
classic	classic	JJ	I-NP	O
Murphy	Murphy	NNP	I-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

7/12/06	7/12/06	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
thickened	thicken	VBN	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
gallbladder	gallbladder	NN	B-NP	O
sludge	sludge	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
,	,	,	O	O
trace	trace	NN	B-VP	O
to	to	TO	B-PP	O
small	small	JJ	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
showed	show	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
x	x	SYM	I-NP	O
2	2	CD	I-NP	O
cm	cm	NN	I-NP	O
intraparenchymal	intraparenchymal	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
temporal	temporal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemorrhagic	hemorrhagic	JJ	B-NP	O
metastasis	metastasis	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
additional	additional	JJ	I-NP	O
smaller	small	JJR	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
attenuation	attenuation	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
parietal	parietal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
were	be	VBD	B-VP	O
arachnoid	arachnoid	JJ	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
convexity	convexity	NN	I-NP	O
also	also	RB	B-ADVP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Hemorrhage	Hemorrhage	NN	B-NP	O
likely	likely	RB	I-NP	O
subarachnoid	subarachnoid	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
quadrigeminal	quadrigeminal	JJ	I-NP	O
plate	plate	NN	I-NP	O
cistern	cistern	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
extending	extend	VBG	B-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
tentorium	tentorium	NN	I-NP	O
.	.	.	O	O

10/30/06	10/30/06	CD	B-NP	O
,	,	,	O	O
repeat	repeat	NN	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
interval	interval	NN	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
intraparenchymal	intraparenchymal	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
temporal	temporal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemorrhagic	hemorrhagic	JJ	B-NP	O
metastasis	metastasis	NN	I-NP	O
.	.	.	O	O

7/6/06	7/6/06	CD	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
with	with	IN	B-PP	O
gadolinium	gadolinium	NN	B-NP	O
unchanged	unchanged	JJ	I-NP	O
parenchymal	parenchymal	JJ	I-NP	O
and	and	CC	I-NP	O
subarachnoid	subarachnoid	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

1/18/06	1/18/06	CD	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
head	head	NN	B-NP	O
,	,	,	O	O
slight	slight	JJ	B-NP	O
interval	interval	NN	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
parietal	parietal	JJ	I-NP	O
subarachnoid	subarachnoid	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
small	small	JJ	B-NP	O
,	,	,	I-NP	O
unchanged	unchanged	JJ	I-NP	O
intraparenchymal	intraparenchymal	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	B-DNA
temporoparietal	temporoparietal	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
quadrigeminal	quadrigeminal	JJ	I-NP	O
cistern	cistern	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
C-spine	C-spine	NN	B-NP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
bony	bony	NN	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
,	,	,	O	O
partially	partially	RB	B-ADVP	O
imaged	image	VBD	B-VP	O
right	right	JJ	B-NP	O
temporal	temporal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
intraparenchymal	intraparenchymal	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
10/30/06	10/30/06	CD	B-NP	O
,	,	,	O	O
findings	finding	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
osteoarthritis	osteoarthritis	NN	B-NP	O
most	most	RBS	B-ADJP	O
marked	marked	JJ	I-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
joint	joint	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
radiographic	radiographic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
displaced	displaced	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
traumatic	traumatic	JJ	B-NP	O
contusion	contusion	NN	I-NP	O
,	,	,	O	O
subdural	subdural	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
and	and	CC	O	O
subarachnoid	subarachnoid	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
now	now	RB	B-ADJP	O
encephalopathic	encephalopathic	JJ	I-ADJP	O
with	with	IN	B-PP	O
hepatotoxicity	hepatotoxicity	NN	B-NP	O
and	and	CC	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
longstanding	longstanding	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Intracranial	Intracranial	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
and	and	CC	I-NP	O
Neurosurgery	Neurosurgery	NNP	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
antiepileptic	antiepileptic	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
ICH	ICH	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
tapering	tapering	NN	I-NP	O
on	on	IN	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
continuos	continuo	NNS	B-NP	O
EEG	EEG	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
PLEDs	PLED	NNS	I-NP	O
though	though	IN	B-SBAR	O
no	no	DT	B-NP	O
frank	frank	NN	I-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
AEDs	AED	NNS	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
and	and	CC	O	O
with	with	IN	B-PP	O
continuing	continue	VBG	B-NP	O
EEG	EEG	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
encephalopathy	encephalopathy	NN	B-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
hepatic	hepatic	JJ	B-NP	O
source	source	NN	I-NP	O
versus	versus	IN	B-PP	O
bleed	bleed	NN	B-NP	O
related	related	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
versus	versus	IN	B-PP	O
medication	medication	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
frequently	frequently	RB	B-ADVP	O
falls	fall	VBZ	B-VP	O
asleep	asleep	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
easy	easy	JJ	B-ADJP	O
to	to	TO	B-VP	O
arouse	arouse	VB	I-VP	O
and	and	CC	O	O
talkative	talkative	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
conversant	conversant	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	O	O
significantly	significantly	RB	B-VP	O
improved	improve	VBN	I-VP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
relative	relative	JJ	B-ADJP	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Phillip	Phillip	NNP	I-NP	O
Arrequin	Arrequin	NNP	I-NP	O
of	of	IN	B-PP	O
Neurosurgery	Neurosurgery	NNP	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
event	event	NN	I-NP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
VFib	VFib	NNP	B-NP	O
.	.	.	O	O

1/18/06	1/18/06	CD	B-NP	O
echo	echo	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
July	July	NNP	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
torsemide	torsemide	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
VFib	VFib	NN	I-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
on	on	IN	B-PP	O
overall	overall	JJ	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
taper	taper	NN	I-NP	O
and	and	CC	I-NP	O
telemetry	telemetry	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
benefit	benefit	NN	I-NP	O
from	from	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Hematologically	Hematologically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
3	3	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
through	through	IN	B-PP	O
1/18/06	1/18/06	CD	B-NP	O
.	.	.	O	O

Received	Receive	VBN	B-NP	O
multiple	multiple	JJ	I-NP	O
FFP	FFP	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
readdressed	readdresse	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stwart	Stwart	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
okayed	okay	VBN	I-VP	O
by	by	IN	B-PP	O
Neurosurgery	Neurosurgery	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Acute-on-chronic	Acute-on-chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
relative	relative	JJ	B-NP	O
prerenal	prerenal	JJ	I-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
and	and	CC	I-NP	O
metolazone	metolazone	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
though	though	IN	B-ADVP	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
scant	scant	JJ	I-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
at	at	IN	B-PP	O
first	first	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
progressed	progress	VBD	B-VP	O
to	to	TO	I-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
requesting	request	VBG	I-VP	O
meals	meal	NNS	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
intermittently	intermittently	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
bili	bili	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
peak	peak	JJ	B-NP	O
AST	AST	NN	I-NP	O
of	of	IN	B-PP	O
111	111	CD	B-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
remained	remain	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
beyond	beyond	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
sludge	sludge	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
LFTs	LFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
Dilantin	Dilantin	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
lactulose	lactulose	NN	B-NP	O
to	to	TO	B-VP	O
relieve	relieve	VB	I-VP	O
encephalopathy	encephalopathy	NN	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
outpatient	outpatient	NN	B-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
regular	regular	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
episodic	episodic	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
chronic	chronic	JJ	I-NP	O
mild	mild	JJ	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
200	200	CD	I-NP	O
to	to	TO	I-NP	O
300	300	CD	I-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
further	further	JJ	B-NP	O
adjustment	adjustment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
dosage	dosage	NN	I-NP	O
.	.	.	O	O

Orthopedic	Orthopedic	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
injury	injury	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
supportive	supportive	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
heparin	heparin	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
pneumoboots	pneumoboot	NNS	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
status	status	NN	I-NP	O
throughout	throughout	IN	B-PP	O
entire	entire	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
headache	headache	NN	I-NP	O
;	;	:	O	O
temperature	temperature	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
100.5	100.5	CD	B-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	B-protein
400	400	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
x5	x5	NN	I-NP	I-protein
doses	dose	NNS	I-NP	I-protein
starting	start	VBG	B-VP	I-protein
1/7/06	1/7/06	CD	B-NP	I-protein
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
daily	daily	RB	B-VP	I-protein
starting	start	VBG	I-VP	I-protein
2/18/06	2/18/06	CD	B-NP	I-protein
,	,	,	O	O
Dulcolax	Dulcolax	NNP	B-NP	O
rectal	rectal	JJ	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
daily	daily	JJ	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
each	each	DT	O	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.15	0.15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
ferrous	ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcu	subcu	NN	I-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
nebulized	nebulize	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
immediate	immediate	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
x1	x1	NN	I-NP	O
starting	start	VBG	B-VP	O
10/8/06	10/8/06	CD	B-NP	O
,	,	,	O	O
lactulose	lactulose	VBP	B-VP	O
20	20	CD	B-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
levocarnitine	levocarnitine	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
sodium	sodium	NN	I-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
quick	quick	VBP	B-VP	O
dissolving	dissolve	VBG	I-VP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Reglan	Reglan	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.	q.	FW	I-ADVP	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
with	with	IN	B-PP	O
hold	hold	NN	B-NP	O
parameters	parameter	NNS	I-NP	O
systemic	systemic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rat	rat	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
oral	oral	JJ	I-NP	O
suspension	suspension	NN	I-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zofran	Zofran	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
x2	x2	NN	I-NP	O
doses	dose	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
sennosides	sennoside	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
simethicone	simethicone	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
bedtime	bedtime	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
mineral	mineral	NN	I-NP	O
capsule	capsule	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Onda	Onda	NNP	B-NP	O
El	El	NNP	I-NP	O
Geeny	Geeny	NNP	I-NP	O
:	:	:	O	O
Memorial	Memorial	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Kimmey	Kimmey	NNP	I-NP	O
of	of	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
622-840-9570	622-840-9570	CD	B-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
closely	closely	RB	B-ADVP	O
and	and	CC	O	O
taper	taper	NN	B-NP	O
torsemide	torsemide	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
becomes	become	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-7135701	5-7135701	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DANCY	DANCY	NNP	B-NP	O
,	,	,	O	O
JARED	JARED	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HARING	HARING	NNP	B-NP	O
,	,	,	O	O
KENDALL	KENDALL	NNP	B-NP	O
DEWEY	DEWEY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1144011	1144011	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/8/06	10/8/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/8/06	10/8/06	CD	B-NP	O

